Cited 30 times in
Lenvatinib for Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma and Candidate Biomarkers Associated with Survival: A Multicenter Study in Korea
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.